Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collastat vs Collaseal for Prevention of Pancreatic Fistula After Pancreatectomy
NCT04357483Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Feb 2018
- Primary completion
- Jul 2020
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of CollaStat in pancreatic fistula (POPF) (2 arms), sponsored by Asan Medical Center. Primary endpoint: Incidence of Postoperative Pancreatic Fistula at 3 months. Status: unknown.
02
Drugs
CollaStat
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT04357483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04357483.